MedTech Barcelona

MedTech Innovation on Advanced Medicine (MedTech Barcelona) is a leading biotech company focused on developing innovative solutions for the healthcare and pharmaceutical sectors. Fully held by Leitat, a pioneering technology centre at both state and European level with over a century of experience, MedTech Barcelona acts as a commercialization platform for the organization’s new developments. ReadyCell, MedTech’s branch of activity, specializes in providing cell-based in vitro tools for the ADME-Tox and DMPK segment. Its product portfolio covers essential applications in drug discovery, such as absorption studies, drug-transporter interactions, and toxicity testing. The company owns a patented technology that allows the shipment of living cells at room temperature, preserving their viability and cellular characteristics, thus streamlining logistics and reducing delivery times. This operation stems from a long-standing collaboration between Leitat and ReadyCell, in which Leitat has been involved since its inception. Together, we have jointly developed the products that ReadyCell now successfully commercializes globally. This agreement aligns with the technology center's commitment to bolstering its biotechnology development and innovation branch. With a well-established global distribution network that spans key markets including the United States, India, and Japan, MedTech Barcelona and its ReadyCell brand will continue to expand their presence, serving over 100 clients from both industry and academia worldwide.